Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Ultraviolet Screening Material	34.64B
Ultraviolet Screening Material Growth	-10.10%
Clopidogrel Camphorsulphonic Acid	5.00B
Clopidogrel Camphorsulphonic Acid Growth	-27.03%
Other	2.93B
Other Growth	49.55%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
International	27.32B
International Growth	-15.82%
South Korea	15.26B
South Korea Growth	2.46%